13th May 2025 Plain language summary: how do race and income influence prostate cancer treatment choices in the United States?
18th Oct 2024 Enzalutamide in metastatic hormone-sensitive prostate cancer: A summary of the ARCHES and ENZAMET follow-up studies
23rd Sep 2024 Prostate-specific antigen levels and quality of life in advanced prostate cancer patients treated with apalutamide: a plain language summary of the SPARTAN and TITAN trials
22nd Jan 2024 The TITAN study: a plain language summary looking at how PSA decline with apalutamide therapy is associated with longer survival and improved outcomes in people with metastatic prostate cancer
